Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Cytotoxicity
100%
Neuroblastoma Cell
100%
Cell Line
100%
Cell Cycle
100%
Cycline
100%
Downregulation
50%
Mouse Model
50%
Upregulation
50%
Gene Expression Assay
50%
Cell Viability
50%
Carboxy Terminal Sequence
50%
Cell Death
50%
Genetic Transcription
50%
Cell Cycle Progression
50%
RNA Polymerase
50%
Enhancer Region
50%
Xenograft
50%
Medicine and Dentistry
Neoplasm
100%
Ganglioneuroblastoma
100%
Neuroblastoma Cell
50%
Cytotoxicity
50%
Cell Line
50%
Cell Cycle
50%
Cyclin-Dependent Kinase
50%
Malignant Neoplasm
25%
Cell Viability
25%
Cell Death
25%
Downregulation
25%
Upregulation
25%
Combination Therapy
25%
Genetic Transcription
25%
Xenograft
25%
Carboxy Terminal Sequence
25%
Gene Expression Profiling
25%
Polymerase
25%
Tumor Regression
25%
Kinase
25%
Enhancer Region
25%
Cell Cycle Progression
25%
RNA Polymerase II
25%
Cyclin-Dependent Kinase 7
25%
Target Validation
25%
Neuroscience
Neuroblastoma
100%
Cell Line
33%
Cytotoxicity
33%
Cell Cycle
33%
Cyclin-Dependent Kinase
33%
Gene Expression
16%
Cell Viability
16%
Cell Death
16%
C-Terminus
16%
Genetic Transcription
16%
Cell Cycle Progression
16%
Enhancer Region
16%
Cyclin Dependent Kinase 7
16%
RNA Polymerase II
16%
Polymerase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Neuroblastoma
100%
Cytotoxicity
33%
Mouse Model
16%
Malignant Neoplasm
16%
Combination Therapy
16%
Cell Viability
16%
Cyclin Dependent Kinase
16%
Tumor Regression
16%
RNA Polymerase II
16%
Cyclin Dependent Kinase 7
16%